The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches. Issue 2 (19th January 2021) - Macaluso, Fabio Salvatore; Fries, Walter; Viola, Anna; Centritto, Andrea; Cappello, Maria; Giuffrida, Enrica; Privitera, Antonino Carlo; Piccillo, Giovita; Magnano, Antonio; Vinci, Elisa; Vassallo, Roberto; Trovatello, Antonino; et al.